$1.93
-0.20[-9.39%]
At close: Apr 19
$1.93
0[0.00%]
After Hours: 7:00AM EDT
Acurx Pharmaceuticals
(NASDAQ:ACXP)Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Analyst Ratings, Price Targets, Predictions
Acurx Pharmaceuticals Inc has a consensus price target of $12.67, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on March 19, 2024, February 28, 2024, and December 15, 2023. With an average price target of $13.33 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 590.85% upside for Acurx Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Alliance Global Partners
Maxim Group
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Acurx Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/19/2024 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 521.76% | HC Wainwright & Co. | Ed Arce | $14 → $12 | Maintains | Buy | Get Alert |
| 02/28/2024 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 625.39% | HC Wainwright & Co. | Ed Arce | → $14 | Reiterates | Buy → Buy | Get Alert |
| 12/15/2023 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 625.39% | HC Wainwright & Co. | Ed Arce | $13 → $14 | Maintains | Buy | Get Alert |
| 11/15/2023 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 573.58% | HC Wainwright & Co. | Ed Arce | → $13 | Reiterates | Buy → Buy | Get Alert |
| 09/13/2023 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 573.58% | HC Wainwright & Co. | Ed Arce | → $13 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2023 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 573.58% | HC Wainwright & Co. | Ed Arce | $14 → $13 | Maintains | Buy | Get Alert |
| 05/15/2023 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 625.39% | HC Wainwright & Co. | Ed Arce | → $14 | Reiterates | Buy → Buy | Get Alert |
| 04/11/2023 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 625.39% | HC Wainwright & Co. | Ed Arce | → $14 | Reiterates | → Buy | Get Alert |
| 03/17/2023 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 625.39% | HC Wainwright & Co. | Ed Arce | → $14 | Reiterates | → Buy | Get Alert |
| 12/19/2022 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 625.39% | HC Wainwright & Co. | Ed Arce | → $14 | Initiates | → Buy | Get Alert |
| 10/20/2022 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 625.39% | Alliance Global Partners | James Molloy | → $14 | Initiates | → Buy | Get Alert |
| 11/29/2021 | ACXP | Buy Now | Acurx Pharmaceuticals | $1.93 | 521.76% | Maxim Group | Jason McCarthy | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Acurx Pharmaceuticals (ACXP)?
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on March 19, 2024. The analyst firm set a price target for $12.00 expecting ACXP to rise to within 12 months (a possible 521.76% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Acurx Pharmaceuticals (ACXP)?
The latest analyst rating for Acurx Pharmaceuticals (NASDAQ: ACXP) was provided by HC Wainwright & Co., and Acurx Pharmaceuticals maintained their buy rating.
When was the last upgrade for Acurx Pharmaceuticals (ACXP)?
There is no last upgrade for Acurx Pharmaceuticals.
When was the last downgrade for Acurx Pharmaceuticals (ACXP)?
There is no last downgrade for Acurx Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Acurx Pharmaceuticals (ACXP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acurx Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acurx Pharmaceuticals was filed on March 19, 2024 so you should expect the next rating to be made available sometime around March 19, 2025.
Is the Analyst Rating Acurx Pharmaceuticals (ACXP) correct?
While ratings are subjective and will change, the latest Acurx Pharmaceuticals (ACXP) rating was a maintained with a price target of $14.00 to $12.00. The current price Acurx Pharmaceuticals (ACXP) is trading at is $1.93, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.